Average Co-Inventor Count = 3.33
ph-index = 38
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Isis Pharmaceuticals, Inc. (109 from 1,035 patents)
2. Ionis Pharmaceuticals, Inc. (78 from 276 patents)
3. Biogen Ma Inc. (6 from 253 patents)
4. Regulus Therapeutics Inc. (4 from 62 patents)
5. Lonis Pharmaceuticals, Inc. (4 from 5 patents)
6. Eli Lilly and Company (3 from 4,452 patents)
7. Alnylam Pharmaceuticals, Inc. (2 from 448 patents)
8. The University of Texas System (1 from 5,506 patents)
9. The University of British Columbia (1 from 934 patents)
10. Alaylam Pharmacueuticals, Inc. (1 from 1 patent)
202 patents:
1. 12509684 - COMPOSITIONS AND METHODS FOR MODULATING APOLIPOPROTEIN C-III EXPRESSION
2. 12291709 - Compositions and methods for modulating apolipoprotein (a) expression
3. 12234447 - Modified compounds and uses thereof
4. 12215321 - Modulators of diacyglycerol acyltransferase 2 (DGAT2)
5. 12152244 - Selective antisense compounds and uses thereof
6. 12110491 - Selective reduction of allelic variants
7. 12091662 - Compositions for modulating tau expression
8. 11959080 - Methods and compositions for inhibiting PMP22 expression
9. 11851655 - Compositions and methods for modulating apolipoprotein (a) expression
10. 11732265 - Compositions and methods for modulating complement factor B expression
11. 11732261 - Selective antisense compounds and uses thereof
12. 11633483 - Modulators of PCSK9 expression
13. 11613752 - Compositions and methods for modulating PKK expression
14. 11591595 - Compositions for modulating Tau expression
15. 11566245 - Oligomeric compounds comprising bicyclic nucleotides and uses thereof